KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 80 filers reported holding KEROS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,291,116 | -23.0% | 28,252 | +11.6% | 0.00% | 0.0% |
| Q1 2024 | $1,675,787 | +89.8% | 25,314 | +14.0% | 0.00% | +100.0% |
| Q4 2023 | $882,791 | +19.0% | 22,203 | -4.6% | 0.00% | 0.0% |
| Q3 2023 | $741,752 | -26.3% | 23,267 | -7.2% | 0.00% | 0.0% |
| Q2 2023 | $1,006,911 | +8.8% | 25,060 | +15.6% | 0.00% | 0.0% |
| Q1 2023 | $925,394 | -8.7% | 21,672 | +2.7% | 0.00% | -50.0% |
| Q4 2022 | $1,013,510 | +38.1% | 21,106 | +8.2% | 0.00% | +100.0% |
| Q3 2022 | $734,000 | +38.8% | 19,511 | +1.9% | 0.00% | 0.0% |
| Q2 2022 | $529,000 | -45.0% | 19,147 | +8.4% | 0.00% | 0.0% |
| Q1 2022 | $961,000 | -15.0% | 17,670 | -8.5% | 0.00% | 0.0% |
| Q4 2021 | $1,130,000 | +51.3% | 19,317 | +2.2% | 0.00% | 0.0% |
| Q3 2021 | $747,000 | -18.3% | 18,895 | -12.2% | 0.00% | 0.0% |
| Q2 2021 | $914,000 | -25.5% | 21,519 | +8.0% | 0.00% | -50.0% |
| Q1 2021 | $1,227,000 | -11.8% | 19,931 | +1.0% | 0.00% | 0.0% |
| Q4 2020 | $1,391,000 | +243.5% | 19,724 | +87.8% | 0.00% | +100.0% |
| Q3 2020 | $405,000 | +2.8% | 10,503 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $394,000 | – | 10,503 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 292,833 | $17,134,000 | 5.65% |
| Deep Track Capital, LP | 1,300,000 | $76,063,000 | 5.37% |
| Octagon Capital Advisors LP | 340,214 | $19,906,000 | 3.87% |
| Opaleye Management Inc. | 265,750 | $15,549,000 | 3.30% |
| First Light Asset Management, LLC | 552,098 | $32,303,000 | 2.31% |
| Altium Capital Management LP | 116,000 | $6,787,000 | 1.87% |
| Nantahala Capital Management | 796,698 | $46,615,000 | 1.64% |
| Orbimed Advisors | 1,679,417 | $98,263,000 | 1.26% |
| Darwin Global Management, Ltd. | 111,500 | $6,524,000 | 1.00% |
| Parkman Healthcare Partners LLC | 69,861 | $4,088,000 | 0.90% |